|
|
 |
|
| Topics > Hemostasis and Thrombosis |
|
Topic News Focus
Jul 29, 2010
Reporting by NATAonline staff
Joint ISBT / NATA Session During the XXXIst International Congress of the ISBT Published: May 2010
During the XXXIst International Congress of the ISBT, which will take place in Berlin, Germany, from June 26 to July 1, 2010, a joint ISBT/NATA sesssion will be dedicated to Clinical Hemotherapy.
The joint session is scheduled on Tuesday, June 29 (14:00-15:30), and will feature three presentations by NATA scientific members:
Better Pre-operative Preparation
L. T. Goodnough (USA)
Operative Interventions to Decrease Blood Loss
D. Thomas (UK)
Pharmacological Interventions
M. Samama (France)
Please click on the link above for more information about the ISBT International Congress.
Fibrin Sealants: Their Role in Blood-Sparing Surgery Published: May 2008
During the 9th Annual NATA Symposium, a satellite symposium entitled "Fibrin Sealants: Their Role in Blood-Sparing Surgery" addressed the role of topical haemostatic agents in reducing blood loss and transfusion requirements in surgical patients. This symposium, supported by an educational grant from Johnson & Johnson Wound Management, was chaired by Prof. Marcela Contreras and Mr. Peter Earnshaw and featured presentations by Dr. Heidi Doughty and Dr. Dafydd Thomas. To view a podcast of the symposium, please click on the link above.
Important Trasylol Safety Information Published: Nov 2007
On November 5, Bayer announced that it will temporarily suspend worldwide marketing of Trasylol (aprotinin injection) until the final results from the Canadian BART trial have been evaluated. The company elected to take this global action following direction from the German BfArM and requests from the FDA, Health Canada and other regulators that Bayer temporarily suspend Trasylol marketing in their respective countries until final BART data were available. The BART trial, a randomized controlled trial in high-risk cardiac surgery patients, was halted after a planned periodic data analysis showed reduced bleeding but also increased all-cause mortality in patients who received aprotinin compared to patients who received either epsilon-aminocaproic acid or tranexamic acid.
 See all news items |
|
Reviewed Articles
Important articles reviewed by the NATAonline editors
Oscarsson A, Gupta A, Fredrikson M, et al.
Published: Mar 2010
To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial.
Br J Anaesth 2010;104(3):305-312.
  
 This randomized double-blind study compared perioperative maintenance with the preoperative withdrawal of aspirin 7 days before ...
Reviewed by:C.-M. Samama
Woodruff SI, Dougherty AL, Dye JL, Mohrle CR, Galarneau MR
Published: Feb 2010
Use of recombinant factor VIIA for control of combat-related haemorrhage.
Emerg Med J 2010;27(2):121-124.
The authors should be congratulated for presenting their negative results. The success rate of approximately 70% in both groups ...
Reviewed by:J.-F. Hardy
Herman CR, Buth KJ, Kent BA, Hirsch GM
Published: Feb 2010
Clopidogrel increases blood transfusion and hemorrhagic complications in patients undergoing cardiac surgery.
Ann Thorac Surg 2010;89(2):397-402.
The authors show, in a large retrospective study, that the shorter the interval between cessation of clopidogrel and cardiac ...
Reviewed by:J.-F. Hardy
All
reviewed in this topic |
|
|
|
|
From the Literature
this week
Jul 29, 2010
Shakur H, Roberts R, Bautista R, et al.
Published: Jul 2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
Lancet 2010;376(9734):23-32.
This is a very important, landmark article describing for the first time the efficacy of an antifibrinolytic, tranexamic acid ...
Colwell CW, Jr., Froimson MI, Mont MA, et al.
Published: Mar 2010
Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin.
J Bone Joint Surg Am 2010;92(3):527-535.
The authors compared the efficacy and safety of a mobile compression device to standard low-molecular-weight heparin (LMWH) ...
Reviewed by:J.-F. Hardy
Oscarsson A, Gupta A, Fredrikson M, et al.
Published: Mar 2010
To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial.
Br J Anaesth 2010;104(3):305-312.
This randomized double-blind study compared perioperative maintenance with the preoperative withdrawal of aspirin 7 days before ...
Reviewed by:J.-F. Hardy
See
archives for this topic |
|
|
|
|
|
TATM Journal
